Does PEMBROLIZUMAB Cause Skin toxicity? 299 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 299 reports of Skin toxicity have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.4% of all adverse event reports for PEMBROLIZUMAB.
299
Reports of Skin toxicity with PEMBROLIZUMAB
0.4%
of all PEMBROLIZUMAB reports
29
Deaths
102
Hospitalizations
How Dangerous Is Skin toxicity From PEMBROLIZUMAB?
Of the 299 reports, 29 (9.7%) resulted in death, 102 (34.1%) required hospitalization, and 10 (3.3%) were considered life-threatening.
Is Skin toxicity Listed in the Official Label?
Yes, Skin toxicity is listed as a known adverse reaction in the official FDA drug label for PEMBROLIZUMAB.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Skin toxicity?
PANITUMUMAB (728)
FLUOROURACIL (597)
OXALIPLATIN (469)
LEUCOVORIN (366)
CARBOPLATIN (322)
IRINOTECAN (308)
PACLITAXEL (305)
CAPECITABINE (269)
CETUXIMAB (254)
CYCLOPHOSPHAMIDE (240)
Which PEMBROLIZUMAB Alternatives Have Lower Skin toxicity Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G